Stockholm 3 reflex (C/T Markers)

An advanced blood test that combines genetic markers, protein biomarkers, and clinical data to evaluate prostate cancer risk with greater accuracy than traditional PSA testing alone. Recommended for men with elevated PSA or a family history of prostate cancer.
Aimed at age 45-74 years, no previous prostate cancer, with an initial PSA test of over 1.5ng/ml.

Location: PortsMed
Initial Consultation: Not Required,